11/20
11:16 am
cing
Cingulate Inc. (NASDAQ: CING) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Medium
Report
Cingulate Inc. (NASDAQ: CING) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
11/7
07:30 am
cing
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
Low
Report
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
10/8
03:15 pm
cing
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
Medium
Report
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show